/ JNJ

/ Earnings

Johnson & Johnson (JNJ) Outperforms Q2 Expectations; Provides Positive Outlook

Johnson & Johnson (JNJ) surpassed expectations in Q2 2025 with a notable increase in earnings per share and revenue.

July 16, 2025

Johnson & Johnson's first-quarter results surpassed expectations with notable growth in sales and earnings.

April 15, 2025

Johnson & Johnson faces a significant legal setback with the dismissal of its $10 billion settlement proposal related to talc product lawsuits.

April 01, 2025

Activist hedge fund Starboard Value has reportedly taken a stake in Kenvue, sparking a pre-market stock surge.

October 21, 2024

Johnson & Johnson's third-quarter performance exceeded expectations, with adjusted EPS of $2.42 against an expected $2.19.

October 15, 2024